MORE►
Lantern Pharma
Renibus Therapeutics CEO Jeff Keyser [Composite photo; original: Renibus Therapeutics]
BioNTX To Honor Renibus Therapeutics CEO with its 2024 Dennis K. Stone Award at iC³ Conference
by Lance Murray | Oct 2, 2024
Renibus CEO Jeff Keyser will be acknowledged as the award recipient at the 10th Annual iC³ Life Science & Healthcare Innovation Summit on Thursday, the first day of the Oct. 3-4 summit at the Loews Arlington Hotel & Convention Center.
by Quincy Preston |
Sep 6, 2024
Dallas-based seed-stage healthcare accelerator Health Wildcatters added nine startups to its growing portfolio, expanding its network of innovators from Texas, the U.S., and Europe. Earlier this year, the accelerator also gained national recognition for its Women in Science and Healthcare initiative, which received a $50,000 award from the U.S. Small Business Administration's Growth Accelerator Fund Competition.
MORE►
by Glenn Hunter |
May 2, 2024
Dallas Innovates, the Dallas Regional Chamber, and Dallas AI have teamed up to launch the inaugural AI 75 list. The 2024 program honors the most significant people in AI in DFW in seven categories—the visionaries, creators, and influencers you need to know.
MORE►
by Lance Murray |
Jan 19, 2024
Marc Chamberlain, M.D., has been appointed as the Chief Medical Officer at Starlight Therapeutics.
Starlight Therapeutics is a Dallas-based Lantern Pharma subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective therapeutic options.
In his role as CMO, Chamberlain will oversee the company’s upcoming clinical trials focused on several serious and complex brain-related conditions: glioblastoma and other high-grade gliomas (aggressive types of brain tumor), brain metastases in adults (secondary brain tumors originating from cancer elsewhere in the body), and two types of pediatric brain tumors — atypical teratoid rhabdoid tumors (ATRT) and diffuse intrinsic pontine glioma (DIPG)....
MORE►
Illustration: LanternPharma
Lantern Pharma Adds VP of Clinical Development, Additional Team Members
by Lance Murray | Mar 2, 2023
Dallas-based Lantern Pharma Inc. has expanded its clinical development team with the addition of Dr. Reggie Ewesuedo as vice president of clinical development, and several additional team members.
Lantern Pharma is a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence and machine learning platform to transform the cost, pace, and timeline of oncology drug discovery and development....
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
by Lance Murray |
Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District.
Here's a full list of winners and finalists.
MORE►
by Lance Murray |
Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas.
Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE►
6 Dallas Innovators You Need to Know Today—and Why
by Alex Edwards | Sep 2, 2021
Sally Beauty tapped its first-ever female CEO, NTT DATA gets a digital transformation leader, and more senior leadership moves this week.
MORE►
by Bella Pinera |
Aug 3, 2021
Panna Sharma has had a hand in four IPOs. The latest was finalized during the middle of COVID for his clinical stage biopharmaceutical oncology firm, Lantern Pharma. Now, he shares the phases to transforming a young private company into the next public success story.
MORE►
by Alex Edwards |
Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
MORE►
by Lance Murray |
Dec 17, 2019
In this weekly roundup of executive and leadership moves by companies and organizations in North Texas, you'll also find news from Colonial Savings, Crawford & Co., Kubota, North Dallas Bank & Trust Co., Amy Stewart Law, and Communities Foundation of Texas.
MORE►
Photo: NicoElNino/iStockPhoto
Digital Assist: 5 North Texas Startups Making Their Mark With Artificial Intelligence
by David Kirkpatrick | Apr 25, 2018
AI startups across the U.S. raised a record $1.9 billion in VC funding during the first quarter of 2018. From marketing to health care, here's a look at North Texas companies disrupting industries with AI tech.
MORE►
